AI Science Tracker
EN

Discovery of novel CSF biomarkers to predict progression in dementia using machine learning

Affiliation not stated in the reviewed material · 23 Dec 2022 · medicine

Discovery

Discovery of novel CSF biomarkers to predict progression in dementia using machine learning

Source check: Source checked. Not independent scientific confirmation.

Finding: The authors report group classification and candidate prioritization, while stating that no candidate is a strong individual predictor. The proteins are exploratory biomarkers; the source does not establish individual-level prognostic accuracy or clinical utility.

Technology: Random forests analyze cerebrospinal-fluid proteomics to classify fast versus slow dementia progression and prioritize TNFRSF4 and TGF-β1 candidates.

Publication: Preprint · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Random forests analyze cerebrospinal-fluid proteomics to classify fast versus slow dementia progression and prioritize TNFRSF4 and TGF-β1 candidates.
Test and result
The authors report group classification and candidate prioritization, while stating that no candidate is a strong individual predictor.
Limitation / still unknown
The proteins are exploratory biomarkers; the source does not establish individual-level prognostic accuracy or clinical utility.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.researchsquare.com/article/rs-2382373/v1

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.